Gold prices climbed as investors awaited crucial meetings between U.S. President Trump and Chinese President Xi Jinping, while also monitoring the fragile ceasefire negotiations with Iran. Market participants are also anticipating U.S. CPI data to gauge the Federal Reserve’s future interest rate decisions.
Dr Reddy’s Laboratories Q4 Results: Cons PAT falls 86% YoY to Rs 221 crore, revenue dips 12%; Rs 8 per share dividend announced
Dr Reddy’s Laboratories Q4 Results: Dr. Reddy’s Laboratories reported a consolidated net profit at Rs 221 crore in the March-ended quarter versus Rs 1,587 crore